Article
13 May 2026
DOL’s Proposed PBM Fee Disclosure Rule: Key Themes From The Public Comments
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
24 Apr 2026
PBM Policy And Legislative Update — Spring 2026
Article
14 Apr 2026
States Continue To Advance New PBM And Drug Pricing Legislation In 2026
Article
21 Oct 2025
Understanding California SB-41: What PBMs Operating In California Need To Know
Article
09 Oct 2025
A Pivotal Week For Pharmaceutical Policy: Trump Administration Advances Tariff And Drug Pricing Initiatives